Skip to main content

Peer Review reports

From: Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs

Original Submission
12 Feb 2021 Submitted Original manuscript
26 Mar 2021 Reviewed Reviewer Report
3 Jun 2021 Author responded Author comments - Ana Miar
Resubmission - Version 2
3 Jun 2021 Submitted Manuscript version 2
15 Jun 2021 Author responded Author comments - Ana Miar
Resubmission - Version 3
15 Jun 2021 Submitted Manuscript version 3
9 Jul 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
15 Jul 2021 Editorially accepted
5 Aug 2021 Article published 10.1186/s12885-021-08616-8

You can find further information about peer review here.

Back to article page